Ipsen is seeking a Head of Evidence Generation – International to lead the development and direction of the international evidence generation strategy (Phase IV, ISS, RWE) across Oncology, Rare Disease and Neurotoxins. The role requires strategic leadership, scientific rigor and collaboration to align with global medical strategies and local market needs.
The role emphasizes building RWE capabilities, managing external data sources, and guiding country teams on project design and regulatory
#J-18808-Ljbffr
Head of International Evidence Generation & RWE employer: Ipsen
Ipsen Biopharm Ltd is an exceptional employer that prioritises a human-centric workplace culture, fostering collaboration and excellence. With a commitment to employee growth, Ipsen offers opportunities for continuous improvement and innovation in the biopharmaceutical field, particularly in vibrant locations like Paris and London. Employees are empowered to thrive, making a meaningful impact on patients and society while enjoying a supportive environment that values diverse perspectives.
